(CLB) Core Laboratories - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: NL0000200384

CLB EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CLB over the last 5 years for every Quarter.

CLB Revenue

This chart shows the Revenue of CLB over the last 5 years for every Quarter.

CLB: Reservoir Analysis, Production Services, Completion Services

Core Laboratories NV is a leading provider of critical reservoir description and production enhancement services to the global oil and gas industry, operating through two primary business segments: Reservoir Description and Production Enhancement. The companys expertise in characterizing petroleum reservoir rock and fluid samples enables clients to optimize production and improve recovery rates. With a strong focus on laboratory-based analytical services and proprietary studies, Core Laboratories supports a range of energy-related activities, including carbon capture and storage, geothermal projects, and mining evaluations.

The companys Production Enhancement segment offers a comprehensive suite of services and products aimed at optimizing well completions, perforations, and stimulations, as well as providing diagnostic services to evaluate the effectiveness of enhanced oil recovery projects. By leveraging its technical expertise and industry knowledge, Core Laboratories helps clients improve the efficiency and productivity of their operations. With a global presence and a history dating back to 1936, the company has established itself as a trusted partner to the energy industry.

From a technical analysis perspective, CLBs current price is below its 20-day and 50-day simple moving averages, indicating a potential downtrend. The stocks 52-week high and low are $24.43 and $10.59, respectively, with the current price near the lower end of this range. The Average True Range (ATR) is 0.89, representing a 7.67% volatility. Using this data, we can forecast that CLB may face resistance around $12.50, with potential support at $10.50. A break above $12.50 could signal a bullish reversal, while a drop below $10.50 may indicate further downside.

Fundamentally, CLBs market capitalization is approximately $578.54 million, with a forward price-to-earnings ratio of 19.76. The companys return on equity is 11.19%, indicating a relatively stable financial performance. By combining this fundamental data with the technical analysis, we can forecast that CLBs stock price may stabilize around $12.00 in the near term, driven by its relatively stable earnings and the potential for increased demand in the energy services sector. However, a sustained recovery above $15.00 would require a significant improvement in industry conditions and the companys financial performance.

Additional Sources for CLB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CLB Stock Overview

Market Cap in USD 582m
Sector Energy
Industry Oil & Gas Equipment & Services
GiC Sub-Industry Oil & Gas Equipment & Services
IPO / Inception 1995-09-20

CLB Stock Ratings

Growth Rating -55.1
Fundamental 28.1
Dividend Rating 12.8
Rel. Strength -38.5
Analysts 3 of 5
Fair Price Momentum 8.59 USD
Fair Price DCF 9.05 USD

CLB Dividends

Dividend Yield 12m 0.27%
Yield on Cost 5y 0.21%
Annual Growth 5y -32.24%
Payout Consistency 87.1%
Payout Ratio 4.8%

CLB Growth Ratios

Growth Correlation 3m -43.4%
Growth Correlation 12m -84.4%
Growth Correlation 5y -59.3%
CAGR 5y -9.95%
CAGR/Max DD 5y -0.13
Sharpe Ratio 12m -1.82
Alpha -58.07
Beta 1.457
Volatility 56.14%
Current Volume 349.4k
Average Volume 20d 369.2k
What is the price of CLB shares?
As of June 26, 2025, the stock is trading at USD 11.37 with a total of 349,368 shares traded.
Over the past week, the price has changed by -9.62%, over one month by +1.25%, over three months by -26.77% and over the past year by -41.31%.
Is Core Laboratories a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Core Laboratories is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.09 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLB is around 8.59 USD . This means that CLB is currently overvalued and has a potential downside of -24.45%.
Is CLB a buy, sell or hold?
Core Laboratories has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold CLB.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 3
  • Sell: 1
  • Strong Sell: 0
What are the forecasts for CLB share price target?
According to our own proprietary Forecast Model, CLB Core Laboratories will be worth about 10.1 in June 2026. The stock is currently trading at 11.37. This means that the stock has a potential downside of -11.43%.
Issuer Target Up/Down from current
Wallstreet Target Price 15.6 37.2%
Analysts Target Price 15.6 37.2%
ValueRay Target Price 10.1 -11.4%